EyePoint Pharmaceuticals, Inc. (EYPT) vs Invivyd, Inc. (IVVD)
A side-by-side comparison of EyePoint Pharmaceuticals, Inc. and Invivyd, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EYPT
EyePoint Pharmaceuticals, Inc.
$3.21HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
IVVD
Invivyd, Inc.
$0.83HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — EYPT vs IVVD
growth of $100 · dividends reinvested · last 5yEYPT -63.8% (-18.4%/yr)IVVD -96.0% (-47.4%/yr)EYPT compounded faster over this window
Log scale — wide-divergence pair
EYPT IVVD
EYPT vs IVVD: by the numbers
- •EYPT is the larger company ($269M vs $245M market cap).
- •Both run net losses; IVVD's is the smaller (-183.90% vs -10994.73% net margin).
Metrics side by side
Valuation
| Metric | EYPT | IVVD |
|---|---|---|
| P/S ratio | 96.35 | 4.19 |
| P/B ratio | 1.61 | 1.35 |
Profitability
| Metric | EYPT | IVVD |
|---|---|---|
| Gross margin | 93.41% | 91.35% |
| Operating margin | -775.98% | -103.99% |
| Net margin | -10994.73% | -183.90% |
| ROE | -184.27% | -59.27% |
| ROIC | -170.19% | -59.90% |
Growth (annualized)
| Metric | EYPT | IVVD |
|---|---|---|
| Revenue CAGR (5Y) | -41.05% | N/A |
| Total return CAGR (5Y) | -21.68% | -51.69% |
Frequently asked
- How have EYPT and IVVD total returns compared?
- Over the past 5 years, EYPT delivered -21.68% and IVVD delivered -51.69% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.